Lead Product(s) : Sodium Levofolinate
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fusilev (Levoleucovorin) is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Lymphoma, Non-Hodgkin.
Product Name : Fusilev
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 12, 2013
Lead Product(s) : Sodium Levofolinate
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
